Literature DB >> 23553791

IFN-γ and TNF-α synergistically induce mesenchymal stem cell impairment and tumorigenesis via NFκB signaling.

Lei Wang1, Yinghua Zhao, Yi Liu, Kentaro Akiyama, Chider Chen, Cunye Qu, Yan Jin, Songtao Shi.   

Abstract

An inflammatory microenvironment may cause organ degenerative diseases and malignant tumors. However, the precise mechanisms of inflammation-induced diseases are not fully understood. Here, we show that the proinflammatory cytokines interferon-γ (IFN-γ) and tumor necrosis factor α (TNF-α) synergistically impair self-renewal and differentiation of mesenchymal stem cells (MSCs) via nuclear factor κB (NFκB)-mediated activation of mothers against decapentaplegic homolog 7 (SMAD7) in ovariectomized (OVX) mice. More interestingly, a long-term elevated levels of IFN-γ and TNF-α result in significantly increased susceptibility to malignant transformation in MSCs through NFκB-mediated upregulation of the oncogenes c-Fos and c-Myc. Depletion of either IFN-γ or TNF-α in OVX mice abolishes MSC impairment and the tendency toward malignant transformation with no NFκB-mediated oncogene activation. Systemic administration of aspirin, which significantly reduces the levels of IFN-γ and TNF-α, results in blockage of MSC deficiency and tumorigenesis by inhibition of NFκB/SMAD7 and NFκB/c-FOS and c-MYC pathways in OVX mice. In summary, this study reveals that inflammation factors, such as IFN-γ and TNF-α, synergistically induce MSC deficiency via NFκB/SMAD7 signaling and tumorigenesis via NFκB-mediated oncogene activation.
Copyright © 2013 AlphaMed Press.

Entities:  

Keywords:  Cancer; Cytokines; Differentiation; Mesenchymal stem cells; Stem cell-microenvironment interactions

Mesh:

Substances:

Year:  2013        PMID: 23553791      PMCID: PMC3706580          DOI: 10.1002/stem.1388

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  61 in total

1.  IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation.

Authors:  Yuhao Gao; Francesco Grassi; Michaela Robbie Ryan; Masakazu Terauchi; Karen Page; Xiaoying Yang; M Neale Weitzmann; Roberto Pacifici
Journal:  J Clin Invest       Date:  2006-12-14       Impact factor: 14.808

2.  Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation.

Authors:  Masako Miura; Yasuo Miura; Hesed M Padilla-Nash; Alfredo A Molinolo; Baojin Fu; Vyomesh Patel; Byoung-Moo Seo; Wataru Sonoyama; Jenny J Zheng; Carl C Baker; Wanjun Chen; Thomas Ried; Songtao Shi
Journal:  Stem Cells       Date:  2005-11-10       Impact factor: 6.277

Review 3.  Estrogen deficiency and bone loss: an inflammatory tale.

Authors:  M Neale Weitzmann; Roberto Pacifici
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

4.  Interleukin-1beta up-regulation of Smad7 via NF-kappaB activation in human chondrocytes.

Authors:  C Baugé; J Attia; S Leclercq; J-P Pujol; P Galéra; K Boumédiene
Journal:  Arthritis Rheum       Date:  2008-01

5.  Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis.

Authors:  Gustavo Duque; Dao Chao Huang; Michael Macoritto; Daniel Rivas; Xian Fang Yang; Louis Georges Ste-Marie; Richard Kremer
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

Review 6.  Diabetes mellitus as a risk factor for cancer: stress or viral etiology?

Authors:  Melanie Cebioglu; Hans H Schild; Olga Golubnitschaja
Journal:  Infect Disord Drug Targets       Date:  2008-06

7.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

Authors:  Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roelofs; Ian Lewis; Edoardo Lanino; Berit Sundberg; Maria Ester Bernardo; Mats Remberger; Giorgio Dini; R Maarten Egeler; Andrea Bacigalupo; Willem Fibbe; Olle Ringdén
Journal:  Lancet       Date:  2008-05-10       Impact factor: 79.321

8.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide.

Authors:  Guangwen Ren; Liying Zhang; Xin Zhao; Guangwu Xu; Yingyu Zhang; Arthur I Roberts; Robert Chunhua Zhao; Yufang Shi
Journal:  Cell Stem Cell       Date:  2008-02-07       Impact factor: 24.633

9.  Gender-related hormonal risk factors for oral cancer.

Authors:  Zsuzsanna Suba
Journal:  Pathol Oncol Res       Date:  2007-10-07       Impact factor: 2.874

10.  Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents.

Authors:  Takayoshi Yamaza; Yasuo Miura; Yanming Bi; Yongzhong Liu; Kentaro Akiyama; Wataru Sonoyama; Voymesh Patel; Silvio Gutkind; Marian Young; Stan Gronthos; Anh Le; Cun-Yu Wang; WanJun Chen; Songtao Shi
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

View more
  48 in total

1.  Transplantation of SHED prevents bone loss in the early phase of ovariectomy-induced osteoporosis.

Authors:  Y Liu; L Wang; S Liu; D Liu; C Chen; X Xu; X Chen; S Shi
Journal:  J Dent Res       Date:  2014-09-24       Impact factor: 6.116

2.  Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.

Authors:  L Wang; S Liu; Y Zhao; D Liu; Y Liu; C Chen; S Karray; S Shi; Y Jin
Journal:  Cell Death Differ       Date:  2015-03-06       Impact factor: 15.828

3.  TNF-α and IFN-γ synergistically inhibit the repairing ability of mesenchymal stem cells on mice colitis and colon cancer.

Authors:  Shaoping Hu; Jiahui Yuan; Jiajia Xu; Xiaomei Li; Gongye Zhang; Qiujuan Ma; Bing Zhang; Tianhui Hu; Gang Song
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

4.  Calreticulin is an effective immunologic adjuvant to tumor-associated antigens.

Authors:  Jun Wang; Zhi Peng Gao; Song Qin; Chang Bai Liu; Li Li Zou
Journal:  Exp Ther Med       Date:  2017-08-22       Impact factor: 2.447

Review 5.  Microenvironmental factors that regulate mesenchymal stem cells: lessons learned from the study of heterotopic ossification.

Authors:  Chen Kan; Lijun Chen; Yangyang Hu; Haimei Lu; Yuyun Li; John A Kessler; Lixin Kan
Journal:  Histol Histopathol       Date:  2017-03-22       Impact factor: 2.303

6.  Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy.

Authors:  Corbin D Jacobs; Stephen G Chun; Jingsheng Yan; Xian-Jin Xie; David A Pistenmaa; Raquibul Hannan; Yair Lotan; Claus G Roehrborn; Kevin S Choe; D W Nathan Kim
Journal:  Cancer Biol Ther       Date:  2014-03-21       Impact factor: 4.742

7.  Clopidogrel Enhances Mesenchymal Stem Cell Proliferation Following Periodontitis.

Authors:  L S Coimbra; J P Steffens; S Alsadun; M L Albiero; C Rossa; R J Pignolo; L C Spolidorio; D T Graves
Journal:  J Dent Res       Date:  2015-07-28       Impact factor: 6.116

Review 8.  Bioengineering a non-genotoxic vector for genetic modification of mesenchymal stem cells.

Authors:  Xuguang Chen; Alireza Nomani; Niket Patel; Faranak S Nouri; Arash Hatefi
Journal:  Biomaterials       Date:  2017-10-20       Impact factor: 12.479

9.  Aspirin treatment improved mesenchymal stem cell immunomodulatory properties via the 15d-PGJ2/PPARγ/TGF-β1 pathway.

Authors:  Jianxia Tang; Jimin Xiong; Tingting Wu; Zhangui Tang; Gang Ding; Chunmei Zhang; Songlin Wang; Yi Liu
Journal:  Stem Cells Dev       Date:  2014-07-01       Impact factor: 3.272

Review 10.  Interplay between inflammatory tumor microenvironment and cancer stem cells.

Authors:  Shijian Zhang; Xi Yang; Lei Wang; Chenping Zhang
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.